
Dr. Stephen Williams
Precision Oncology Scientist
Get to Know Dr. Williams
Dr. Williams is a dedicated and innovative healthcare scientist with more than 12 years of experience in oncology, immunology, and metabolism research. He is proficient in clinical trial design, molecular profiling, and data interpretation, with a strong commitment to addressing cancer health disparities and advancing patient care.
Dr. Williams is adept at fostering cross-functional collaborations, developing educational materials, and mentoring the next generation of health professionals. He has a proven ability to integrate scientific expertise into clinical decision-making and strategic health care planning. Dr. Williams has been recognized for excellence in research and leadership through numerous awards and peer-reviewed publications.
Prior to joining the team at MD Anderson Cancer Center, Dr. Williams completed his Post-doctoral research fellowship with an emphasis on Medical Genetics at Baylor College of Medicine in Houston, Texas. He also worked at Meharry Medical College in Nashville, Tennessee from 2016-2022 as a research associate and Ph.D. candidate, receiving his Doctor of Philosophy degree with emphasis in Biochemistry and Cancer Biology in May 2022.
Dr. Williams has received several awards and recognitions, including:
- 10 under 10: 2023 Distinguished Young Alumni Award, Meharry Medical College
- 2022-2023 FDA-AACR Oncology Educational Fellow
- Maximizing Access Committee (MAC) member, American Society for Biochemistry and Molecular Biology, (2022-2025 term)
- National Institutes of Health T32 Postdoctoral Fellowship- Medical Genetics, 2022-2024
- Student and Early Career Investigator Scholar, American Association for Cancer Research (2021)
Mesothelioma is a rare type of cancer, and Dr. Williams is committed to helping Mesothelioma Guide share medically accurate information about the disease, treatment options, and more for patients and their loved ones. As a medical reviewer, his track record in cancer biology and precision oncology is invaluable to the visitors of the Mesothelioma Guide website.
Disclaimer: Dr. Stephen Williams’ work as the medical reviewer for Mesothelioma Guide’s website is not in any way affiliated with or a representation of MD Anderson Cancer Center.
AI Summary of Dr. Stephen Williams
Dr. Stephen Williams is a highly skilled scientist specializing in Precision Oncology at the MD Anderson Cancer Center in Houston, Texas. With over 12 years of experience, he has a deep understanding of cancer research, immunology, and metabolism. Dr. Williams is dedicated to improving the understanding and treatment of cancer by exploring new ways to personalize therapies for individual patients. His expertise in clinical trial design and molecular profiling allows him to contribute valuable insights into how cancer develops and how it can be effectively treated.
In addition to his work at MD Anderson, Dr. Williams has contributed to patient education and communication by serving as a medical reviewer and content creator for Mesothelioma Guide since 2024. He has helped ensure that the information provided on the website is both accurate and easy to understand for individuals and families facing the challenges of mesothelioma. His efforts support the goal of making complex medical topics accessible to everyone, fostering a sense of trust and clarity for those seeking guidance about their diagnosis and treatment options.
Dr. Williams's background includes a post-doctoral fellowship in Medical Genetics at Baylor College of Medicine and extensive research experience at Meharry Medical College. His scholarly work has earned him numerous awards, such as the Distinguished Young Alumni Award from Meharry Medical College and fellowships from prestigious organizations like the NIH and AACR. His work focuses not only on advancing cancer science but also on addressing disparities in healthcare, ensuring more equitable access to innovative treatments. Through his research, mentoring, and educational outreach, Dr. Williams aims to enhance the quality of care for people affected by cancer and to support the next generation of health professionals.

